|
Jul 25
|
Ascendis Pharma A/S (ASND) Delivers Positive Trial Results for Hypoparathyroidism Treatment
|
|
Jul 24
|
High Growth Tech Stocks In The US Market
|
|
Jul 24
|
High Growth Tech Stocks In The US For July 2025
|
|
Jul 23
|
High Growth Tech Stocks In US To Watch July 2025
|
|
Jul 23
|
US High Growth Tech Stocks To Watch In July 2025
|
|
Jul 22
|
Phase II and Phase III Catalyst Monitor: Q3 2025 Outlook Report - Upcoming FDA Decisions Drive Momentum in Biopharma with Key Catalysts Across GHD, PKU, Presbyopia, and Wet AMD Treatments
|
|
Jul 21
|
Exploring 3 High Growth Tech Stocks In The US Market
|
|
Jul 18
|
US High Growth Tech Stocks To Watch For Potential Gains
|
|
Jun 27
|
Exploring Three High Growth Tech Stocks In The US Market
|
|
Jun 27
|
Exploring 3 High Growth Tech Stocks in the US Market
|
|
Jun 26
|
Exploring High Growth Tech Stocks In The US Market
|
|
Jun 25
|
Exploring US High Growth Tech Stocks For Potential Opportunities
|
|
Jun 25
|
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
|
|
Jun 25
|
US High Growth Tech Stocks To Watch In June 2025
|
|
Jun 24
|
High Growth Tech Stocks To Watch In US June 2025
|
|
Jun 24
|
Exploring US High Growth Tech Stocks To Watch In June 2025
|
|
Jun 24
|
Oppenheimer Hikes Ascendis Pharma Price Target on Strong Yorvipath Demand Outlook
|
|
Jun 23
|
High Growth Tech Stocks in US for June 2025
|
|
May 14
|
Ascendis Pharma A/S (ASND): Among the Best Growth Stocks to Buy and Hold for the Long Term
|
|
May 13
|
New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon® CNP (Navepegritide)
|